Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Manta Network | 2023 | Series A | $25.0M | Boston |
| NFTGo | 2023 | Series A | $4.0M | Singapore |
| Abdera Therapeutics | 2023 | Series B | $142.0M | Vancouver |
| Allorion Therapeutics | 2023 | Series B | $50.0M | Natick |
| Matrixport | 2023 | Series C | $38.0M | Singapore |
| Structure Therapeutics | 2025 | Post-IPO Equity | Undisclosed | South San Francisco |
| Sanegene Bio | 2025 | Series B | $110.0M | Woburn |
| Rhino Federated Computing | 2026 | Series A | Undisclosed | Boston |
| Platelet BioGenesis | 2021 | Series B | Undisclosed | Watertown |
| Caidya | 2025 | Private Equity | Undisclosed | Raleigh |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | Manta Network | Series A | $25.0M | Boston, United States |
| 27 | NFTGo | Series A | $4.0M | Singapore, Singapore |
| 28 | Abdera Therapeutics | Series B | $142.0M | Vancouver, Canada |
| 29 | Allorion Therapeutics | Series B | $50.0M | Natick, United States |
| 30 | Matrixport | Series C | $38.0M | Singapore, Singapore |
| 31 | Structure Therapeutics | Post-IPO Equity | Undisclosed | South San Francisco, United States |
| 32 | Sanegene Bio | Series B | $110.0M | Woburn, United States |
| 33 | Rhino Federated Computing | Series A | Undisclosed | Boston, United States |
| 34 | Platelet BioGenesis | Series B | Undisclosed | Watertown, United States |
| 35 | Caidya | Private Equity | Undisclosed | Raleigh, United States |
Manta Network is building a secure and interoperable future with Zero-Knowledge.
NFTGo is a NFT data aggregator where users can find information about NFT.
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.
Matrixport is a digital assets financial services platform where users can invest, trade, and leverage crypto assets.
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
The revolutionary platform for decentralized AI collaborations - unlock data silos without data sharing.
Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.
Caidya is a clinical research organization that provides personalized solutions for various therapeutic areas.
BIT provides digital asset financial infrastructure and services to institutional and professional investors globally.
Powering precision proteomics to enable to the earliest detection of disease.
Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.
CODE 27 develops software solutions focused on digital platforms, data systems, and custom technology applications.
Video Rebirth is a private limited company that is established with shares.
Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider.
Stairway Medical is a developer of implantable brain-computer interface technology.
CSR Biotech is a biological research company that provides cell imaging and data processing services.
Tingsheng Technology develops intra cardiac ultrasound ICE products.
QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.
Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management products.
Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.
Sano Dynamics is a producer of hydraulic system core components and hydraulic industrial robots.
Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection and wound repair.
Qiming Venture Partners has invested in 370 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Medical, Health Care, Biotechnology, Therapeutics, Cryptocurrency. The firm invests across 34 different industry categories.
Among tracked funding rounds, Candid Therapeutics received $505.0M in a Undisclosed round. Qiming Venture Partners's total known invested capital is $11.0B.
Qiming Venture Partners's average investment size is $54.4M across its portfolio of 370 companies.
Recent Qiming Venture Partners portfolio additions include Manta Network, NFTGo, Abdera Therapeutics, Allorion Therapeutics, Matrixport. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors